Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,057,909
-$20,698,347 QoQ
Shares Held
161,826
-48.4% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 282 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. BNTX ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in BNTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,057,909 | 161,826 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $35,756,256 | 313,789 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,872,071 | 318,869 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,194,952 | 52,202 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,851,888 | 52,595 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,560,049 | 62,157 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $6,584,996 | 60,613 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,541,961 | 60,613 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,587,932 | 60,913 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $117,814,241 | 784,278 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $169,450,957 | 1,256,309 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $275,527,108 | 1,847,935 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $260,415,272 | 1,526,825 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $396,424,989 | 1,537,723 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $317,716,408 | 1,163,839 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $454,624,384 | 2,030,661 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $226,558,986 | 2,074,906 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $128,379,407 | 1,574,821 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $82,912,894 | 1,197,644 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,821,780 | 297,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||